Clinical Trial Update: Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether dexmedetomidine used as first-line sedation reduces delirium in pediatric intensive care patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine (Precedex) (dexmedetomidine)

Snippet

Sponsor: University Hospital, Tours | Conditions: Delirium in the Intensive Care Unit | Phase 3 | Status: NOT_YET_RECRUITING